Regulation - Research, Markets & Marketing


Popular Filters

Indian pharma threatened by trend of shifting R&D operations overseas: survey


Red tape is putting India's multi-billion dollar worth pharmaceutical industry at risk, with most of…

Asia-PacificGenericsMarkets & MarketingPharmaceuticalRegulationResearch

News briefs: Lexicon's IBS drug; Sanofi Pasteur launch in Thailand; Tranzyme drops TZP-102


US drug developer Lexicon Pharmaceuticals (Nasdaq: LXRX) saw its shares leap 9.1% to $2.04 in premarket…

DiabetesGastro-intestinalsLexicon PharmaceuticalsLX1033Markets & MarketingPharmaceuticalRegulationResearchSanofiSanofi PasteurTranzymeTZP-102Vaccines

Structural defects holding back growth of Russia's pharmaceutical industry


Despite having grown significant since 2009 and set to be worth $10.7 million by 2014, there are some…

EuropeMarkets & MarketingPharmaceuticalRegulationResearch

Medicines Australia sets up new taskforce on transparency for payments to doctors


Medicines Australia has invited the Australian Medical Association, the Royal Australian College of Physicians,…

Asia-PacificFinancialMarkets & MarketingPharmaceuticalRegulationResearch

Russia's pharma industry impresses as economy continues to grow; report


The Russian pharmaceutical industry will continue to expand due to government initiatives and increased…

EuropeMarkets & MarketingPharmaceuticalRegulationResearch

Back to top